Inflamac Lotio Emuls 1% Tb 50g - Joint and Muscle Pain Relief
Inflamac Lotio Emuls 1 % Tb 50 g
-
11.82 USD
- Availability: Outstock
- Brand: SPIRIG HEALTHCARE AG
- Product Code: 2942114
- ATC-code M02AA15
- EAN 7680553750022
Ingredients:
Description
What is Inflamac Lotio and when is it used?
Inflamac Lotio is an analgesic and anti-inflammatory preparation for external use. This cooling and non-greasy emulsion can be rubbed in easily and gets through the skin to the site of the inflammation.
Inflamac Lotio is suitable
- for the local treatment of pain, inflammation and swelling such as after sprains, bruises and strains;
- as a supportive measure for the local treatment of rheumatic complaints of the musculoskeletal system.
When should Inflamac Lotio not be used be used?
Inflamac Lotio must not be used in case of hypersensitivity to the active substance diclofenac or other pain-relieving and anti-inflammatory substances, in particular acetylsalicylic acid/aspirin, and in case of hypersensitivity to one of the excipients.
When is caution required when using Inflamac Lotio?
Inflamac Lotio must not be applied to open skin wounds (e.g. abrasions, cuts) or to eczematous skin.
Inflamac Lotio should not be used on large areas for a long time, unless prescribed by a doctor.
Make sure that Inflamac Lotio does not come into contact with the eyes and mucous membranes.
Inform your doctor, pharmacist or druggist if you have already used similar products (rheumatism ointments) and these have led to allergic reactions, if you have other suffer from illnesses, have allergies or are taking or using other medicines (including those you bought yourself!)!
Can Inflamac Lotio be used during pregnancy or breastfeeding?
Inflamac Lotio must not be used during pregnancy and breastfeeding unless specifically prescribed by a doctor.
How do you use Inflamac Lotio?
Adults
Depending on the size of the painful areas or areas to be treated an amount of 2 - 4 g Inflamac Lotio (the size of a hazelnut or walnut) is applied 3 - 4 times a day, rubbed in lightly or massaged in for muscle pain.
Inform your doctor if the symptoms have not improved after 2 weeks or have even worsened.
Children
The use and safety of Inflamac Lotio in children has not yet been systematically tested.
Follow the dosage given in the package leaflet or prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.
What side effects can Inflamac Lotio have?
The following side effects can occur when using Inflamac Lotio:
Some rare or very rare side effects can be serious. If any of the following side effects occur, stop using Inflamac Lotio and tell your doctor immediately:
- severe skin rash with blisters, hives
- wheezing, shortness of breath asthma
- swelling of the face, lips, tongue and throat.
These other side effects are usually mild and temporary:
- Common: skin rash, itching, redness, burning sensation
- In very rare cases, increased sensitivity to sunlight may occur. Signs of this are sunburn with itching, swelling and blistering.
- Not known: burning sensation at the application site, dry skin.
If you notice any side effects, talk to your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet.
What else needs to be taken into account?
The medicine may only be used up to the date marked «EXP» on the container.
Storage instructions
Keep out of the reach of children. Store at room temperature (15-25°C).
Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed technical information.
What does Inflamac Lotio contain?
Active substances
10 mg Diclofenacum natricum
Excipients
Purified water, ethanol, triglycerides, polyacrylamide, isoparaffin, laureth-7, dimeticone, tocopherol.
Authorization number
< p>55375 (Swissmedic)Where can you get Inflamac Lotio? Which packs are available?
In pharmacies and drugstores, without a doctor's prescription.
Tubes of 50 and 100 g.
Authorization holder
Spirig HealthCare AG, 4622 Egerkingen
This package leaflet was last checked by the drug authority (Swissmedic) in June 2021.